Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 17.67
+0.29 (1.67%)
Jul 31, 2026, 3:05 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 10.51 billion as of July 31, 2026. Its market cap has decreased by -7.87% in one year.
Market Cap
10.51B
Enterprise Value
7.76B
Revenue
1.20B
Ranking
n/a
PE Ratio
56.08
Stock Price
17.67
ChartMarket Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 10.51B, a decrease of -62.61%. That is a compound annual growth rate of -19.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 10.51B | -5.15% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 11.85B |
| Inner Mongolia Furui Medical Science | 11.47B |
| Chengzhi | 11.03B |
| HitGen | 10.54B |
| Staidson (Beijing) BioPharmaceuticals | 10.00B |
| Pacific Shuanglin Bio-pharmacy | 9.70B |
| GemPharmatech | 9.51B |
| Shanghai Medicilon | 9.41B |